BarclayHedge: Hedge Funds Add 2.11% In Sept.

Oct 15 2013 | 12:41pm ET

Hedge funds posted widespread gains in September but failed to match the broader markets, buoyed by a rally in stocks.

Seventeen of BarclayHedge's 18 industry indices gained ground last month. The overall Barclay Hedge Fund Index added 2.11% and is up 7.3% on the year.

"The Fed's decision to delay tapering surprised investors and drove equity prices higher through mid-month," BarclayHedge founder Sol Waksman said. "Fears over the possible failure of U.S. budget and debt-ceiling negotiations gained momentum and equity markets sold off in the second half of September, but equities remained profitable on the month as measured by a gain of 5% for the MSCI World Index."

The best-performing strategy in September—and on the year—is healthcare and biotechnology, up 4.26% on the month and 27.91% on the year. "The passage of the Affordable Care Act in the U.S., coupled with the expectation of greater demand for healthcare services due to increases in both population and life expectancy, have had a very positive impact on the sector."

Equity long-bias funds rose 3.65% in September (15.24% YTD), technology funds 3.35% (9.38% YTD), emerging markets funds 2.92%, Pacific Rim equities 2.62% (17.2% YTD) and European equities 2.03%.

Short-bias funds were the only losers on the month, dropping 3.55%. The strategy is down 19.84% on the year.

The Barclay Fund of Funds Index returned 1.33% in September (4.95% YTD).

In Depth

Financial Industry Blockchain Consortium R3 To Open-Source Platform Code

Oct 20 2016 | 9:03pm ET

Bitcoin's blockchain technology has spawned a flurry of activity among fintech startups...


U.S. Trust's Beard: The Rapid Growth of the Art Lending Industry

Oct 7 2016 | 10:55pm ET

Alternative investment managers have emerged as some of the most significant art...

Guest Contributor

Hedge Fund Marketing – Tips for Your Initial Sales Meeting

Sep 29 2016 | 5:46pm ET

There are two main goals a hedge fund should have for an initial in-person sales...